|http://ghr.nlm.nih.gov/ A service of the U.S. National Library of Medicine®|
The official name of this gene is “versican.”
VCAN is the gene's official symbol. The VCAN gene is also known by other names, listed below.
The VCAN gene provides instructions for making a protein called versican. Versican is a type of protein known as a proteoglycan, which means it has several sugar molecules attached to it. Versican is found in the extracellular matrix of many different tissues and organs. The extracellular matrix is the intricate lattice of proteins and other molecules that forms in the spaces between cells. Versican interacts with many proteins and molecules to facilitate the assembly of the extracellular matrix and ensure its stability. Within the eye, versican interacts with other proteins to maintain the structure and gel-like consistency of the thick clear fluid that fills the eyeball (the vitreous).
Researchers have proposed several additional functions for versican. This protein likely helps regulate cell growth and division, the attachment of cells to one another (cell adhesion), and cell movement (migration). Studies suggest that versican plays a role in forming new blood vessels (angiogenesis), wound healing, inflammation, and preventing the growth of cancerous tumors. Versican also regulates the activity of several growth factors, which control a diverse range of processes important for cell growth.
Four different versions (isoforms) of the versican protein are produced from the VCAN gene. These isoforms (called V0, V1, V2, and V3) vary by size and by their location within the body.
The VCAN gene belongs to a family of genes called proteoglycans (proteoglycans).
A gene family is a group of genes that share important characteristics. Classifying individual genes into families helps researchers describe how genes are related to each other. For more information, see What are gene families? (http://ghr.nlm.nih.gov/handbook/howgeneswork/genefamilies) in the Handbook.
At least 11 mutations in the VCAN gene have been found to cause Wagner syndrome, a condition that leads to progressive vision loss starting in childhood or early adulthood. The VCAN gene mutations that cause Wagner syndrome disrupt the way the gene's instructions are used to make versican. These mutations occur in two areas of the gene called intron 7 and exon 8; mutations in these regions lead to a decrease in the production of versican isoforms V0 and V1 and an increase in the production of isoforms V2 and V3. Researchers believe that this imbalance of versican isoforms in the vitreous impairs versican's interaction with other proteins, causing the vitreous to become unstable. This lack of stability in the vitreous affects other areas of the eye and contributes to the vision problems that occur in people with Wagner syndrome. It is unknown why VCAN gene mutations seem solely to affect vision.
Cytogenetic Location: 5q14.3
Molecular Location on chromosome 5: base pairs 83,471,673 to 83,582,302
The VCAN gene is located on the long (q) arm of chromosome 5 at position 14.3.
More precisely, the VCAN gene is located from base pair 83,471,673 to base pair 83,582,302 on chromosome 5.
See How do geneticists indicate the location of a gene? (http://ghr.nlm.nih.gov/handbook/howgeneswork/genelocation) in the Handbook.
You and your healthcare professional may find the following resources about VCAN helpful.
You may also be interested in these resources, which are designed for genetics professionals and researchers.
See How are genetic conditions and genes named? (http://ghr.nlm.nih.gov/handbook/mutationsanddisorders/naming) in the Handbook.
angiogenesis ; cell ; cell adhesion ; exon ; extracellular ; extracellular matrix ; gene ; inflammation ; intron ; isoforms ; protein ; proteoglycan ; sulfate ; syndrome
You may find definitions for these and many other terms in the Genetics Home Reference Glossary (http://ghr.nlm.nih.gov/glossary).
The resources on this site should not be used as a substitute for professional medical care or advice. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional. See How can I find a genetics professional in my area? (http://ghr.nlm.nih.gov/handbook/consult/findingprofessional) in the Handbook.